Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 22

1.

Role of thiamine in Huntington's disease pathogenesis: In vitro studies.

Gruber-Bzura BM, Krzysztoń-Russjan J, Bubko I, Syska J, Jaworska M, Zmysłowski A, Rosłon M, Drozd J, Drozd E, Majorczyk E, Anuszewska EL.

Adv Clin Exp Med. 2017 Aug;26(5):751-760. doi: 10.17219/acem/63091.

2.

Pathophysiology and molecular basis of selected metabolic abnormalities in Huntington's disease.

Krzysztoń-Russjan J.

Postepy Hig Med Dosw (Online). 2016 Dec 30;70(0):1331-1342. doi: 10.5604/17322693.1227557. Review.

3.

Up-regulation of glutathione-related genes, enzyme activities and transport proteins in human cervical cancer cells treated with doxorubicin.

Drozd E, Krzysztoń-Russjan J, Marczewska J, Drozd J, Bubko I, Bielak M, Lubelska K, Wiktorska K, Chilmonczyk Z, Anuszewska E, Gruber-Bzura B.

Biomed Pharmacother. 2016 Oct;83:397-406. doi: 10.1016/j.biopha.2016.06.051. Epub 2016 Jul 15.

PMID:
27424321
4.

Doxorubicin Treatment of Cancer Cells Impairs Reverse Transcription and Affects the Interpretation of RT-qPCR Results.

Drozd E, Krzysztoń-Russjan J, Gruber B.

Cancer Genomics Proteomics. 2016 Mar-Apr;13(2):161-70.

PMID:
26912806
5.

Cytotoxicity Evaluation and Crystallochemical Analysis of a Novel and Commercially Available Bone Substitute Material.

Bojar W, Ciach T, Kucharska M, Maurin J, Gruber BM, Krzysztoń-Russjan J, Bubko I, Anuszewska EL.

Adv Clin Exp Med. 2015 May-Jun;24(3):511-6. doi: 10.17219/acem/22599.

6.

Huntington' disease--imbalance of amino acid levels in plasma of patients and mutation carriers.

Gruber B, Kłaczkow G, Jaworska M, Krzysztoń-Russjan J, Anuszewska EL, Zielonka D, Klimberg A, Marcinkowski JT.

Ann Agric Environ Med. 2013;20(4):779-83.

7.

Interactions between drugs and sulforaphane modulate the drug metabolism enzymatic system.

Lubelska K, Milczarek M, Modzelewska K, Krzysztoń-Russjan J, Fronczyk K, Wiktorska K.

Pharmacol Rep. 2012;64(5):1243-52.

8.

A study of molecular changes relating to energy metabolism and cellular stress in people with Huntington's disease: looking for biomarkers.

Krzysztoń-Russjan J, Zielonka D, Jackiewicz J, Kuśmirek S, Bubko I, Klimberg A, Marcinkowski JT, Anuszewska EL.

J Bioenerg Biomembr. 2013 Feb;45(1-2):71-85. doi: 10.1007/s10863-012-9479-3. Epub 2012 Oct 16.

PMID:
23070563
9.

Formation and preclinical evaluation of a new alloplastic injectable bone substitute material.

Bojar W, Kucharska M, Bubak G, Ciach T, Koperski Ł, Jastrzębski Z, Gruber BM, Krzysztoń-Russjan J, Marczewska J, Anuszewska EL, Drozd E, Brynk T.

Acta Bioeng Biomech. 2012;14(1):39-44.

PMID:
22742431
10.

Modulation of apoptosis protein profiles--role of P-gp in HeLa cells exposed to doxorubicin.

Gruber BM, Krzysztoń-Russjan J, Bubko I, Koronkiewicz M, Anuszewska EL.

Cancer Genomics Proteomics. 2012 May-Jun;9(3):153-61.

PMID:
22593250
11.

Isothiocyanate-drug interactions in the human adenocarcinoma cell line Caco-2.

Lubelska K, Misiewicz-Krzemińska I, Milczarek M, Krzysztoń-Russjan J, Anuszewska E, Modzelewska K, Wiktorska K.

Mol Cell Biochem. 2012 Aug;367(1-2):19-29. doi: 10.1007/s11010-012-1314-y. Epub 2012 Apr 18.

PMID:
22527941
12.

Possible role of HSP60 in synergistic action of anthracyclines and sulindac in HeLa cells.

Gruber BM, Krzysztoń-Russjan J, Bubko I, Anuszewska EL.

Acta Pol Pharm. 2010 Nov-Dec;67(6):620-4.

13.

Synergistic action of doxorubicin and sulindac in human cervix carcinoma cells - studies on possible mechanisms.

Gruber BM, Bubko I, Krzyszton-Russjan J, Anuszewska EL.

Med Sci Monit. 2010 Jan;16(1):BR45-51.

PMID:
20037485
14.

Epidemiological investigation of nosocomial outbreak of staphylococcal skin diseases in neonatal ward.

Kurlenda J, Grinholc M, Krzysztoń-Russjan J, Wiśniewska K.

Antonie Van Leeuwenhoek. 2009 May;95(4):387-94. doi: 10.1007/s10482-009-9318-7. Epub 2009 Feb 21.

PMID:
19234757
15.

Usefulness of multiple-locus VNTR fingerprinting in detection of clonality of community- and hospital-acquired Staphylococcus aureus isolates.

Luczak-Kadlubowska A, Sabat A, Tambic-Andrasevic A, Payerl-Pal M, Krzyszton-Russjan J, Hryniewicz W.

Antonie Van Leeuwenhoek. 2008 Nov;94(4):543-53. doi: 10.1007/s10482-008-9271-x. Epub 2008 Jul 27.

PMID:
18661286
16.

Characterization of coagulase-negative staphylococci isolated from cases of ostitis and osteomyelitis.

Wilk I, Ekiel A, Kłuciński P, Krzysztoń-Russjan J, Martirosian G.

Pol J Microbiol. 2006;55(3):175-8.

PMID:
17338269
17.

Characteristics of Staphylococcus aureus strains isolated in Poland in 1996 to 2004 that were deficient in species-specific proteins.

Luczak-Kadlubowska A, Krzyszton-Russjan J, Hryniewicz W.

J Clin Microbiol. 2006 Nov;44(11):4018-24. Epub 2006 Sep 27.

18.

First community-acquired methicillin-resistant Staphylococcus aureus (MRSA) strains in Croatia.

Krzysztoń-Russjan J, Tambic-Andrasevic A, Bukovski S, Sabat A, Hryniewicz W.

Clin Microbiol Infect. 2006 Jul;12(7):697-8. No abstract available.

19.

Comparison of multiple-locus variable-number tandem-repeat analysis with pulsed-field gel electrophoresis, spa typing, and multilocus sequence typing for clonal characterization of Staphylococcus aureus isolates.

Malachowa N, Sabat A, Gniadkowski M, Krzyszton-Russjan J, Empel J, Miedzobrodzki J, Kosowska-Shick K, Appelbaum PC, Hryniewicz W.

J Clin Microbiol. 2005 Jul;43(7):3095-100.

20.

Clonal structure of the methicillin-resistant Staphylococcus aureus (MRSA) population in Poland: revision and update.

Krzysztoń-Russjan J, Empel J, Lêski T, Gniadkowski M, Hryniewicz W.

Microb Drug Resist. 2005 Summer;11(2):127-36.

PMID:
15910226
21.

New method for typing Staphylococcus aureus strains: multiple-locus variable-number tandem repeat analysis of polymorphism and genetic relationships of clinical isolates.

Sabat A, Krzyszton-Russjan J, Strzalka W, Filipek R, Kosowska K, Hryniewicz W, Travis J, Potempa J.

J Clin Microbiol. 2003 Apr;41(4):1801-4.

22.

The first Staphylococcus aureus isolates with reduced susceptibility to vancomycin in Poland.

Krzysztoń-Russjan J, Gniadkowski M, Połowniak-Pracka H, Hagmajer E, Hryniewicz W.

J Antimicrob Chemother. 2002 Dec;50(6):1065-9.

PMID:
12461035

Supplemental Content

Loading ...
Support Center